Question-and-Answer Session
Operator
(Operator Instructions) We'll take our first question from Peter Bye from Jefferies & Co.
Peter Bye - Jefferies & Co.
Thanks, guys, I appreciate it. Just on the guidance, even since you announced the currency has moved quite a bit and you are able to hold your guidance on the top-line, am I just thinking too much that its kind of a rounding error, or are you feeling somewhat more confident about some of your other parts of the business?
Jim Mazzo
Well, I think it's a combination of things, Peter. Again, we are growing US in the cataract business. We expect growth, obviously, in our eye care business. So you see strong growth in things like Japan and Asia Pacific, where really its non-euro, so I think we have enough flexibility to continue to hit the '08 timeframe. I think the key is obviously what are the currency levels in '09? And that's why we are planning now for and will give you more illustration on our '09 numbers at the end of the fourth quarter for next year.
Peter Bye - Jefferies & Co.
Okay, Great. Just with the liquidity and some of the other just even changes against that you've reported. Have you seen any further disruption on the capital equipment cycle, either here in the US or overseas, or it's pretty much still status quo?
Jim Mazzo
I will let Michael add to it. I will tell you I still think its pretty status quo. I don't think I've seen anybody accelerating capital equipment, although we are continuing to place excimers and femto; it's just not at the rate we expected. Again, with iFS, that will help. Do you anything to add there, Michael?
Michael Lambert
No, Peter, I think Jim covered it.
Peter Bye - Jefferies & Co.
Okay, great. Just two quick ones then, Michael, your guidance is pro forma but you don't give sort f a schedule. We backed into sort of $0.14 on a pro forma in Q3. Is that right or about right, or is that better to talk about offline?
Michael Lambert
Yes, I think, if you think about it, Peter, let me sort of talk through it for people. If you think about that sort of adjusted Q3 '08 EPS, right, diluted GAAP of $0.11, and we were reduced by about $4 million on the combined effect of the following things; the restructuring items, which was about $0.11, reduced by $0.11; the unrealized gain on derivatives, which was a $0.06, and gain on investment of about [$1 million or $0.01]. So it does net out to about a $0.04 delta.
- To read the full transcript on Seeking Alpha, click here »
